InsideArbitrage Event Driven Monitor – June 26, 2026
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage TECH: The acquisition of Bio-Techne Corporation (TECH) by Merck KGaA for a…
Written byAsif SuriaSource: InsideArbitrage
Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage TECH: The acquisition of Bio-Techne Corporation (TECH) by Merck KGaA for a closing value of $11.3 billion. Bio-Techne shareholders will receive $73 per share in cash, representing a premium of 23.98% over the stock’s last close.